BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 25320245)

  • 1. Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
    Umezu T; Tadokoro H; Azuma K; Yoshizawa S; Ohyashiki K; Ohyashiki JH
    Blood; 2014 Dec; 124(25):3748-57. PubMed ID: 25320245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxic exosomes promote angiogenesis.
    Fan GC
    Blood; 2014 Dec; 124(25):3669-70. PubMed ID: 25498451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126.
    Liu W; Li L; Rong Y; Qian D; Chen J; Zhou Z; Luo Y; Jiang D; Cheng L; Zhao S; Kong F; Wang J; Zhou Z; Xu T; Gong F; Huang Y; Gu C; Zhao X; Bai J; Wang F; Zhao W; Zhang L; Li X; Yin G; Fan J; Cai W
    Acta Biomater; 2020 Feb; 103():196-212. PubMed ID: 31857259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1.
    Hsu YL; Hung JY; Chang WA; Lin YS; Pan YC; Tsai PH; Wu CY; Kuo PL
    Oncogene; 2017 Aug; 36(34):4929-4942. PubMed ID: 28436951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
    Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
    Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes increased angiogenesis in papillary thyroid cancer microenvironment.
    Wu F; Li F; Lin X; Xu F; Cui RR; Zhong JY; Zhu T; Shan SK; Liao XB; Yuan LQ; Mo ZH
    Endocr Relat Cancer; 2019 May; 26(5):525-538. PubMed ID: 30870812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal HMGB1 derived from hypoxia-conditioned bone marrow mesenchymal stem cells increases angiogenesis via the JNK/HIF-1α pathway.
    Gao W; He R; Ren J; Zhang W; Wang K; Zhu L; Liang T
    FEBS Open Bio; 2021 May; 11(5):1364-1373. PubMed ID: 33711197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes promote bone marrow angiogenesis in hematologic neoplasia: the role of hypoxia.
    Ohyashiki JH; Umezu T; Ohyashiki K
    Curr Opin Hematol; 2016 May; 23(3):268-73. PubMed ID: 26866730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells.
    Matsuura Y; Wada H; Eguchi H; Gotoh K; Kobayashi S; Kinoshita M; Kubo M; Hayashi K; Iwagami Y; Yamada D; Asaoka T; Noda T; Kawamoto K; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
    Dig Dis Sci; 2019 Mar; 64(3):792-802. PubMed ID: 30465177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argonaute 2 promotes myeloma angiogenesis via microRNA dysregulation.
    Wu S; Yu W; Qu X; Wang R; Xu J; Zhang Q; Xu J; Li J; Chen L
    J Hematol Oncol; 2014 May; 7():40. PubMed ID: 24886719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxic Cancer-Secreted Exosomal miR-182-5p Promotes Glioblastoma Angiogenesis by Targeting Kruppel-like Factor 2 and 4.
    Li J; Yuan H; Xu H; Zhao H; Xiong N
    Mol Cancer Res; 2020 Aug; 18(8):1218-1231. PubMed ID: 32366676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic pancreatic cancer derived exosomal miR-30b-5p promotes tumor angiogenesis by inhibiting GJA1 expression.
    Chen K; Wang Q; Liu X; Wang F; Yang Y; Tian X
    Int J Biol Sci; 2022; 18(3):1220-1237. PubMed ID: 35173549
    [No Abstract]   [Full Text] [Related]  

  • 13. CircCDR1as Suppresses Bone Microvascular Endothelial Cell Activity and Angiogenesis Through Targeting miR-135b/ FIH-1 Axis.
    Mao Z; Liu G; Xiao GY; Zhao C; Zou YC
    Orthop Surg; 2021 Apr; 13(2):573-582. PubMed ID: 33619902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma.
    Wu XG; Zhou CF; Zhang YM; Yan RM; Wei WF; Chen XJ; Yi HY; Liang LJ; Fan LS; Liang L; Wu S; Wang W
    Angiogenesis; 2019 Aug; 22(3):397-410. PubMed ID: 30993566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth.
    Aakula A; Leivonen SK; Hintsanen P; Aittokallio T; Ceder Y; Børresen-Dale AL; Perälä M; Östling P; Kallioniemi O
    Mol Oncol; 2015 Aug; 9(7):1287-300. PubMed ID: 25907805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity.
    Raimondi L; Amodio N; Di Martino MT; Altomare E; Leotta M; Caracciolo D; Gullà A; Neri A; Taverna S; D'Aquila P; Alessandro R; Giordano A; Tagliaferri P; Tassone P
    Oncotarget; 2014 May; 5(10):3039-54. PubMed ID: 24839982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-targeting of multiple microRNAs on factor-Inhibiting hypoxia-Inducible factor gene for the pathogenesis of head and neck carcinomas.
    Kao SY; Tsai MM; Wu CH; Chen JJ; Tseng SH; Lin SC; Chang KW
    Head Neck; 2016 Apr; 38(4):522-8. PubMed ID: 25351569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
    Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
    Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal mir-625-3p derived from hypoxic lung cancer cells facilitates metastasis by targeting SCAI.
    Zhang Y; Qian K; Liu X; Zhao X; Zhao T; Lu G
    Mol Biol Rep; 2022 Oct; 49(10):9275-9281. PubMed ID: 35988100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma.
    Lu J; Liu QH; Wang F; Tan JJ; Deng YQ; Peng XH; Liu X; Zhang B; Xu X; Li XP
    J Exp Clin Cancer Res; 2018 Jul; 37(1):147. PubMed ID: 30001734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.